What is a pheochromocytoma?

A pheochromocytoma is a rare tumor that forms in the adrenal glands. These two glands sit above the kidneys and make hormones like adrenaline, which help control heart rate and blood pressure. When a tumor develops, it can cause the body to make too much of these hormones.

Pheochromocytomas are sometimes called pheos. They start in chromaffin cells, a type of cell that makes hormones. These cells are also involved in related tumors called paragangliomas, which can form in other parts of the body.

Many pheochromocytomas grow slowly and are noncancerous, though some can be cancerous. Even when they’re not cancerous, most still need treatment.

Because these tumors are rare and complex, it’s important to get care from an experienced team. At Penn Medicine, specialists from different fields work together to diagnose the tumors and create a treatment plan tailored to each person.

Signs and symptoms of pheochromocytoma

Sometimes pheochromocytoma symptoms are mild or hard to notice. Other times, people experience:

  • High blood pressure
  • A rapid or pounding heartbeat
  • Headaches
  • Pale skin
  • Sweating
  • Tremors or shaking

Less commonly, symptoms include abdominal pain, unintended weight loss, anxiety, nervousness, or panic attacks.

What causes a pheochromocytoma?

The exact cause is often unknown. In most cases, there are no known lifestyle or environmental risk factors.

Sometimes, pheochromocytomas are linked to inherited genetic changes passed down through families. If a parent carries one of these changes, each child has a 50% chance of inheriting it. But inheriting a gene change doesn’t mean someone will definitely develop a tumor.

Some genetic changes can affect how these tumors behave. They may increase the risk of tumors in both adrenal glands or make them more likely to spread or come back after treatment.

These same genetic changes may also be linked to other conditions, including neurofibromatosis type 1, multiple endocrine neoplasia type 2 (MEN2), Von Hippel-Lindau disease, and certain pancreatic neuroendocrine tumors.

At Penn Medicine, we offer genetic testing and counseling for people with pheochromocytomas and related conditions. Understanding genetic risk can help identify tumors earlier and guide screening and treatment plans for individuals and their families.

Pheochromocytoma diagnosis

Most people are diagnosed between ages 30 and 50. Sometimes, these tumors are found during imaging tests for another reason. Others seek care because of symptoms or a family history.

Because symptoms can look like many other conditions, diagnosis can be challenging. An evaluation typically includes a physical exam, family health history, blood or urine tests, and imaging.

Treating pheochromocytoma

Our specialists work across many fields to treat pheochromocytoma. We consider your symptoms, overall health, and treatment goals to create a plan that supports your quality of life. Treatment depends on the tumor, hormone levels, and whether it has spread.

Expert pheochromocytoma care

Our team includes doctors with deep experience in treating these rare tumors. Each case is reviewed by a tumor board through our Neuroendocrine Tumor Program, where experts develop a personalized treatment plan. We care for about 200 people with pheochromocytomas and paragangliomas each year.

In our program, you’ll find:

  • Experienced care team: Many of our doctors are national leaders who also teach and lead research.
  • Advanced treatments: We offer access to clinical trials and study new approaches, especially for tumors that spread.
  • Complex surgical care: This includes procedures that may preserve part of the adrenal gland when possible.
  • Recognized expertise: We are a Center of Excellence designated by the Pheo Para Alliance, a leading advocacy and research organization, and one of a small number of centers worldwide with this recognition.
  • Ongoing support: A nurse coordinator helps schedule visits, answer questions, and guide care.
National Cancer Institute Designated Comprehensive Cancer Center badge on top of shot of hospital

Rated “exceptional” by The National Cancer Institute

Penn Medicine’s Abramson Cancer Center is a world leader in cancer research, patient care, and education. Our status as a national leader in cancer care is reflected in our continuous designation as a Comprehensive Cancer Center by the National Cancer Institute (NCI) since 1973, one of 7 such centers in the United States. The ACC is also a member of the National Comprehensive Cancer Network, one of a select few cancer centers in the U.S., that are working to promote equitable access to high-quality, advanced cancer care.

Related specialties

Schedule an appointment

We can help you schedule an appointment or you can search our directory of specialists.